The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...

The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...

Blockbuster diabetes and weight loss drugs, known as GLP-1 treatments, could help reduced the rate of overdoses and ...

The British government believes weight-loss drugs could play a role in its push to reduce the number of long-term unemployed ...

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use ...

The plans to use give unemployed overweight people Mounjaro were introduced by Wes Streeting earlier this week.

Left untreated, obstructive sleep apnea is linked to daytime sleepiness and an increased risk of anxiety, diabetes, ...

Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...